10.03.2018 Views

(kinja.com) Top 5 Antibody Humanization Service Providers in the Antibody Market

Founded in 2002 in New Jersey, United States, GenScript serves as a partner for researchers in basic life sciences, translational and biomedical fields as well as early-stage drug development.

Founded in 2002 in New Jersey, United States, GenScript serves as a partner for researchers in basic life sciences, translational and biomedical fields as well as early-stage drug development.

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Top</strong> 5 <strong>Antibody</strong> <strong>Humanization</strong> <strong>Service</strong> <strong>Providers</strong> <strong>in</strong> <strong>the</strong> <strong>Antibody</strong> <strong>Market</strong><br />

<strong>Top</strong> 1 GenScript<br />

Founded <strong>in</strong> 2002 <strong>in</strong> New Jersey, United States, GenScript serves as a partner for researchers <strong>in</strong><br />

basic life sciences, translational and biomedical fields as well as early-stage drug development.<br />

As a one-stop supplier for <strong>the</strong>rapeutic antibody discovery and development, GenScript is proud to<br />

offer <strong>in</strong>tegrated antibody humanization and aff<strong>in</strong>ity maturation service. Comb<strong>in</strong><strong>in</strong>g <strong>in</strong> silico<br />

CDR-graft<strong>in</strong>g, structure-based back mutation, and, supported by our patented FASEBA(Fast<br />

Screen<strong>in</strong>g for Expression, Biophysical-properties and Aff<strong>in</strong>ity) screen<strong>in</strong>g, Biacore Surface<br />

Plasmon Resonance platform and functional assay platform, <strong>the</strong> antibody humanization service is<br />

offered at GenScript to generate humanized antibody ma<strong>in</strong>ta<strong>in</strong><strong>in</strong>g <strong>the</strong> aff<strong>in</strong>ity and specificity of<br />

parental antibody and optimized activity, productivity and <strong>the</strong>rmostability. Seamlessly <strong>in</strong>tegrated<br />

with humanization, <strong>the</strong> aff<strong>in</strong>ity maturation service will cont<strong>in</strong>uously improve <strong>the</strong> aff<strong>in</strong>ity by 10 to<br />

50 folds.<br />

<strong>Top</strong> 2 S<strong>in</strong>o Biological<br />

Founded by MIT professor, Dr. Daniel I.C. Wang, and his former student, Dr. Liangzhi Xie, <strong>in</strong><br />

2007, S<strong>in</strong>o Biological Inc. is a develop<strong>in</strong>g biological reagents manufacturer located <strong>in</strong> Beij<strong>in</strong>g,<br />

offer<strong>in</strong>g a <strong>com</strong>prehensive set of premium quality reagents, all of which are produced <strong>in</strong>-house and<br />

cover a broad range of life science research and drug development.<br />

S<strong>in</strong>o Biological's antibody humanization experience covers not only mouse antibody but also<br />

rabbit monoclonal antibody. Our record speed for antibody humanization was 2 weeks, <strong>in</strong>clud<strong>in</strong>g<br />

antibody molecule structure modification, high-throughput antibody production by transient<br />

transfection, antibody characterization and bioactivity measurement.<br />

<strong>Top</strong> 3 Creative Biolabs<br />

S<strong>in</strong>ce its establishment <strong>in</strong> 2005 <strong>in</strong> New York, Creative Biolabs is specialized <strong>in</strong> provid<strong>in</strong>g custom<br />

biotechnology and pharmaceutical services that cover <strong>the</strong> full scope of biotechnology needs of<br />

early antibody development and drug discovery. It has extensive experience to offer <strong>the</strong> antibody<br />

humanization service for <strong>the</strong>rapeutic and diagnostic development. It has successfully performed<br />

15 mouse/rat humanization projects dur<strong>in</strong>g <strong>the</strong> past decade with at least one humanized antibody<br />

entered <strong>the</strong> cl<strong>in</strong>ical trials. It also provides humanization service to antibodies derived from o<strong>the</strong>r<br />

species, such as non-human primate (NHP), rabbit, dog, chicken, llama and etc.<br />

As a means of circumvent<strong>in</strong>g <strong>com</strong>mon problems, Creative Biolabs has developed three antibody<br />

humanization strategies that can preserve <strong>the</strong> specificity and aff<strong>in</strong>ity of <strong>the</strong> antibody toward <strong>the</strong><br />

antigen whereas significantly or <strong>com</strong>pletely elim<strong>in</strong>ate <strong>the</strong> immunogenicity of <strong>the</strong> antibody <strong>in</strong><br />

humans. The first approach is CDR graft<strong>in</strong>g and <strong>the</strong> second is cha<strong>in</strong> shuffl<strong>in</strong>g. These two methods<br />

are all based on phage display of humanized scFv variants and selection of high-aff<strong>in</strong>ity


humanized b<strong>in</strong>ders through bio-pann<strong>in</strong>g. The third method, humanized IgG library screen<strong>in</strong>g, is<br />

somehow unique. It will make a library of humanized whole IgG to be displayed on <strong>the</strong> surface of<br />

mammalian cells and <strong>the</strong>n high aff<strong>in</strong>ity b<strong>in</strong>ders will be sorted by FACS.<br />

<strong>Top</strong> 4 Fusion Antibodies<br />

Fusion Antibodies is a Contract Research Organisation (CRO) established <strong>in</strong> 2001 and located<br />

about 6 miles outside Belfast city centre <strong>in</strong> Nor<strong>the</strong>rn Ireland, UK. Its mission is to enable<br />

biopharmaceutical and diagnostic <strong>com</strong>panies to develop <strong>in</strong>novative products <strong>in</strong> a timely and<br />

cost-effective manner for <strong>the</strong> benefit of <strong>the</strong> global healthcare <strong>in</strong>dustry.<br />

Built on decades of <strong>com</strong>b<strong>in</strong>ed experience <strong>in</strong> <strong>the</strong> antibody development <strong>in</strong>dustry, its CDRx TM<br />

platform enables a robust, reliable and accurate modernized version of <strong>the</strong> CDR graft<strong>in</strong>g technique.<br />

It identifies and <strong>com</strong>b<strong>in</strong>es <strong>the</strong> essential sequences from antibody variable doma<strong>in</strong>s <strong>in</strong>to human<br />

donor sequences to create a panel of full length humanized antibodies for expression. The Fusion<br />

Antibodies humanization platform produces antibodies which are <strong>com</strong>pliant with <strong>the</strong> WHO/INN<br />

def<strong>in</strong>itions of a humanized antibody to receive <strong>the</strong> -zu- species orig<strong>in</strong> substem.<br />

<strong>Top</strong> 5 Absolute <strong>Antibody</strong><br />

Absolute <strong>Antibody</strong> was founded <strong>in</strong> Oxford, UK, <strong>in</strong> August 2012, with <strong>the</strong> vision that all antibody<br />

users should be able to use re<strong>com</strong>b<strong>in</strong>ant antibodies, which are absolutely def<strong>in</strong>ed by <strong>the</strong>ir am<strong>in</strong>o<br />

acid sequence. Ra<strong>the</strong>r than creat<strong>in</strong>g entirely new antibodies (or antibody-like molecules), it is<br />

build<strong>in</strong>g a catalog by tak<strong>in</strong>g exist<strong>in</strong>g antibodies (often from hybridomas) <strong>the</strong>n manufactur<strong>in</strong>g <strong>the</strong>m<br />

<strong>in</strong> a superior way and improv<strong>in</strong>g <strong>the</strong>ir usefulness by eng<strong>in</strong>eer<strong>in</strong>g.<br />

Absolute <strong>Antibody</strong> delivers a panel of humanized variants from your clone, and guarantee to<br />

produce a variant with <strong>com</strong>parable activity to <strong>the</strong> parent. Its process also identifies variants with<br />

preferential manufactur<strong>in</strong>g criteria (e.g. high expression, low aggregation).<br />

https://mybiotech2.<strong>k<strong>in</strong>ja</strong>.<strong>com</strong>/top-5-antibody-humanization-service-providers-<strong>in</strong>-<strong>the</strong>-an-18236048<br />

80?rev=1520498490661

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!